{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Severe hypertriglyceridaemia",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_fibrates",
          "name": "Fibrates"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_niacin",
          "name": "Niacin"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_omega_3_fatty_acids",
          "name": "Omega-3 fatty acids"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_statins",
          "name": "Statins"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_ezetimibe",
          "name": "Ezetimibe"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_lomitapide",
          "name": "Lomitapide"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_pcsk9_inhibitors",
          "name": "PCSK9 inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_triglyceride_lowering_agents",
          "name": "Triglyceride-lowering agents"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_cetilistat",
          "name": "Cetilistat"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_orlistat",
          "name": "Orlistat"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_bempedoic_acid",
          "name": "Bempedoic acid"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_sofosbuvir",
          "name": "Sofosbuvir"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_fibrates",
          "type": "Drug",
          "label": "Fibrates",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_niacin",
          "type": "Drug",
          "label": "Niacin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_omega_3_fatty_acids",
          "type": "Drug",
          "label": "Omega-3 fatty acids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_statins",
          "type": "Drug",
          "label": "Statins",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ezetimibe",
          "type": "Drug",
          "label": "Ezetimibe",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lomitapide",
          "type": "Drug",
          "label": "Lomitapide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_pcsk9_inhibitors",
          "type": "Drug",
          "label": "PCSK9 inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_triglyceride_lowering_agents",
          "type": "Drug",
          "label": "Triglyceride-lowering agents",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_severe_hypertriglyceridaemia",
          "type": "Disease",
          "label": "Severe hypertriglyceridaemia",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_lipid_metabolism",
          "type": "Pathway",
          "label": "Lipid metabolism",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_ppar_alpha",
          "type": "Target",
          "label": "PPAR-alpha",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_lpl",
          "type": "Target",
          "label": "Lipoprotein lipase",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_improved_lipid_profile",
          "type": "Phenotype",
          "label": "Improved lipid profile",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_fibrates",
          "target": "target_ppar_alpha",
          "relation": "activates",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知对 PPAR-alpha 的活化作用"
        },
        {
          "source": "drug_niacin",
          "target": "target_lpl",
          "relation": "activates",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "强化脂蛋白酯酶活性"
        },
        {
          "source": "drug_omega_3_fatty_acids",
          "target": "target_lpl",
          "relation": "activates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "常识：改善甘油三酯代谢"
        },
        {
          "source": "drug_statins",
          "target": "pathway_lipid_metabolism",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "普遍应用于脂质代谢通路"
        },
        {
          "source": "drug_ezetimibe",
          "target": "pathway_lipid_metabolism",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通过抑制胆固醇吸收参与"
        },
        {
          "source": "drug_lomitapide",
          "target": "target_lpl",
          "relation": "inhibits",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "通过抑制 VLDL 产生作用"
        },
        {
          "source": "drug_pcsk9_inhibitors",
          "target": "target_lpl",
          "relation": "activates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "通过降低 LDL 受体降解"
        },
        {
          "source": "drug_triglyceride_lowering_agents",
          "target": "pathway_lipid_metabolism",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "针对甘油三酯代谢的综合治疗"
        },
        {
          "source": "target_ppar_alpha",
          "target": "phenotype_improved_lipid_profile",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "PPAR-alpha 通路影响血脂"
        },
        {
          "source": "target_lpl",
          "target": "phenotype_improved_lipid_profile",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "影响甘油三酯清除"
        },
        {
          "source": "pathway_lipid_metabolism",
          "target": "disease_severe_hypertriglyceridaemia",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "脂质代谢失常与病症关联"
        },
        {
          "source": "phenotype_improved_lipid_profile",
          "target": "disease_severe_hypertriglyceridaemia",
          "relation": "inhibits",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "改善表型可降低疾病风险"
        }
      ]
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "通过 PPAR-alpha 与脂蛋白酯酶靶点，影响脂质代谢，与疾病进程密切相关，多个药物均有潜在作用",
        "confidence": "high"
      },
      {
        "id": "C2",
        "text": "改善甘油三酯水平的药物可直接影响严重高甘油三酯血症相关表型",
        "confidence": "medium"
      }
    ],
    "assumptions": [
      "这些药物能够有效达到靶器官，并发挥作用"
    ],
    "uncertainties": [
      "个体反应存在变异，长期效果及安全性需要进一步研究"
    ],
    "next_focus_for_pi": [
      "是否需进一步探索其他药物的补充机制"
    ]
  }
}